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ABSTRACT
Background: Cardiovascular disease is the number one cause of death globally and is projected to 
remain the leading cause of death. If the trend is allowed to continue, by 2015 an 
estimated 20 million people will die from cardiovascular disease (mainly because of
myocardial infarction and strokes). The number of cardiovascular disease cases in 
Malaysia has increased to 14% in five years from 96,000 cases in 1995 to 110,000 
cases in 2000.
Methods: The cost to treat patients admitted to Universiti Kebangsaan Malaysia Medical 
Center (UKMMC) Malaysia, diagnosed with Acute Uncomplicated ST Elevated 
Myocardial Infarction (STEMI) was calculated by using two different 
methodologies, namely step down costing methodology and activity based costing 
using clinical pathway.
Results: Cost for each stay per day at the cardiology ward using the step down methodology 
is RM596.42.  The treatment cost is estimated from RM1, 789.26 to RM 4,771.36. 
The average cost per episode for STEMI care with the average length of stay for 5.6 
days is RM3, 340(SD ±596.42. The cost of coronary PCI procedure in step costing 
is RM 13,950.00. Hence, the total cost  incurs for STEMI with PCI is RM 
17,290.00(SD ±596.42) by using step down method. (an average cost per episode is 
RM3,340,  plus the cost of coronary procedure of RM 13,950.00 . However by using 
the ABC the cost of STEMI (PCI) with an average length of stay for 5.6 days is RM 
20,431.39. The study showed the ABC method was higher by 15.3% than the step 
down costing.
Conclusion: The cost in managing STEMI (PCI) with the average length of stay of 5.6 days was 
calculated by using two different methodologies, namely step down costing 
methodology and activity based costing. Cost of treatment  calculated by using 
activity based costing are higher because all resources used are incorporated in 
detail. The ABC method was higher by 15.3% than the step down costing. The 
difference is within 80-20 rules and the biggest percentage of cost in both methods 
is procedure or PCI cost.
Keywords: Treatment cost of STEMI, step down costing, activity based costing, clinical 
pathway.
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INTRODUCTION
Cardiovascular disease is the number one 
cause of death globally and is projected to 
remain the leading cause of death. An 
estimated 17.5 million people died from 
cardiovascular disease in 2005, representing 
30% of all global death. 7.6 million of these 
cases were due to heart attack and 5.7 million 
were due to stroke. About 80% of these cases
occurred in low and middle income countries. 
If this trend is allowed to continue, by 2015 an 
estimated 20 million people will die from 
cardiovascular disease (mainly from 
myocardial infarction and strokes) 1
Myocardial infarction is a leading cause 
of morbidity and mortality in the United 
States. Approximately 1.3 million cases of non 
fatal myocardial infarction are reported each 
year, for an annual incidence rate of 
approximately 600 cases per 100,000 people. 
The proportion of patients diagnosed with non 
ST Elevation Myocardial Infarction compared 
with ST Elevation Myocardial Infarction has 
progressively increased2.
The number of cardiovascular disease 
cases in Malaysia has increased to 14% in five 
years from 96,000 cases in 1995 to 110,000 
cases in 2000. It is the leading cause of death 
in the country claiming a third of all its 
patients. In 2001, approximately 20 percent of 
all death at the Ministry of Health hospitals 
was due to myocardial infarction and strokes. 
Two thirds of these deaths were due to 
myocardial infarction and the rest were 
strokes3. In 2004, 14.45% of both heart disease 
and disease of pulmonary circulation became 
the second cause of death at the Ministry of 
Health hospitals.”
Managing cardiovascular disease in 
hospitals is expensive in term of treatment 
cost. Study conducted by Herrey et al5 in 
Ireland hospital showed that the average cost 
of treatment for myocardial infarction is 3,976 
pound sterling with average length of stay is 
7.9 days. In that study, the average cost of 
treatment per day was estimated as 501 pound 
sterling per day. Fifty percent of hospital cost 
was due to ward service. From the total 
treatment cost, cost for procedure is 35% and 
pharmacy is 7%5. This average cost of 
treatment of STEMI in Ireland is lower than 
average cost of treatment of STEMI in France 
in 1999 that 5,566 pound sterling6. But this 
average cost in Ireland is similar to the 
treatment cost of STEMI in Belgium Hospital 
in 1998, which was calculated to be 3,675 
pound sterling7. Treatment cost of STEMI 
nowadays has increased significantly, because 
of increasing role of surgical 1992 to 1994 
showed that average cost of STEMI was 2,333 
pound sterling8. Study in Mater Ireland 
hospital from Spain in 1995 found average 
cost of STEMI was 2,445 pound sterling9.
A cardiology inpatient care based on step 
down costing, shows an estimated cost of 
treatment for STEMI without co morbidity and 
complication (IR-DRG 05331) of RM 3,699 
(1056.9USD) with an average length of stay of 
5.5 days10. However, there is no study yet on 
the differences of costs between step down 
costing method and activity based costing 
method for cost treatment of STEMI at 
UKMMC.
There are two different methods that can 
be used to estimate the cost of treatment in 
hospitals. These are: step down costing method 
and activity based costing (ABC). Step down 
costing involves breaking down departments 
or divisions expenditures to obtain operation-
level cost.  There are two different methods of 
“step down” costing; they are "per-diems" 
costing and "case mix" costing. Per-diems 
costs are calculated by dividing the total acute 
inpatient costs of providing care by the number 
of patient days to give an “average” cost per 
patient per day. The case mix costing method 
goes further than the per diems costing by 
dividing patients into more homogeneous 
groups (called case-mix groups) that are 
clinically meaningful and that can be expected 
to use similar amounts of hospital resources11, 
12.
Step down Costing method has limitation 
that no adjustments are made for differences in 
patient characteristics that are likely to affect 
resource utilization (i.e. Case-mix), rendering 
it less accurate. However, as described in 
Mugford et al15, it does offer reliable mean
estimates. Step down costing is easier to carry 
out for a number of reasons (i.e. less data 
intensive, fewer research skill needed, data can 
be collected from routine sources) and thus it 
is more popular13,14.
UKMMC is the first hospital that has 
implemented case-mix system in Malaysia 
since 2002. UKMMC has been routinely 
conducting the case-mix based step down 
costing for its case-mix system.
Activity based costing or ABC is a 
method for developing cost estimates in which 
the calculation is sub divided into discrete, 
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quantifiable activities or a work unit. Activity 
based costing in hospital means that measuring 
cost of every resource used by a 
specific patient14. ABC has some 
disadvantages such as requires more intensive 
primary data collection, slow and more 
expensive, need properly trained staff, not 
necessary accurate (operators may change their 
behavior), difficult to estimate, and require 
expensive and specialized software for data 
collection, but it gives data on inter-patient 
variation11,15.
The method of costing using ABC can be 
calculated by using clinical pathway. Clinical 
pathway is an interdisciplinary plan of care 
that outlines the optimal sequencing and 
timing of intervention for patients with a 
particular diagnosis, procedure or symptom.
UKMMC has developed clinical pathway of 
STEMI (thrombolysis pathway and primary 
percutaneus coronary intervention pathway) 
with a collaborative effort among cardiologist, 
community health and emergency department 
at UKMMC. Clinical pathways are a necessary
part of process costing, analyzing and 
optimizing. The economical data associated 
with clinical pathway provides the basis for an 
efficient controlling. Therefore the clinical 
pathway costing can be used as the de facto 
activity based costing. 
This study aims to compare step down 
costing method and ABC (using clinical 
pathway) method in developing cost of 
treatment for uncomplicated acute STEMI 
(PCI) at UKMMC.
METHODS
For the purpose of this study, we had 
calculated the cost of treatment of 31 patients
admitted, with diagnosed Acute 
Uncomplicated ST Elevated Myocardial 
Infarction (STEMI) at the Universiti 
Kebangsaan Malaysia Medical Center 
(UKMMC0 and underwent percutaneous 
coronary intervention (PCI) procedure. To
receive treatment, these patients were admitted 
to the Coronary Care Unit (CCU), Coronary 
Rehabilitation Ward (CRW) and Cardiology 
Ward.
To develop the cost of treatment by using 
the step down methodology (case-mix 
costing), for all patients admitted to the above 
mentioned wards, in year 2009. Whereas, for 
the development of cost of treatment using the 
activity based costing, we randomly selected 
31 patients admitted to the cardiology 
department between February 2009 till 
October 2009.
The instrument used in calculating cost 
using step down costing method was template 
of step down costing, including the hospital 
basic data, and documentation from the ward. 
The instrument for activity based costing was 
general format of clinical pathways of STEMI 
(PCI pathway).
All available data was gathered, updated 
continuously and added into database. A 
statistical software, “Statistical package for 
Social Science” (SPSS) 17.0 was used. 
Statistical tests applied with the degree of 
significance p<0.05.
The cost of treatment for step down
costing was calculated by using Clinical Cost 
Modeling (CCM) Software version 2.1. CCM 
software performs costing calculation after the 
basic cost data is put in according to 
predefined format. Output windows in the 
CCM software will show cost per day in 
respective ward. Cost of treatment per day in 
medical ward was chosen as the cost of 
treatment for STEMI. Cost per day in medical 
ward then multiplied by the respective 
patient’s length of stay in medical ward to 
obtain the cost of treatment for that episode of 
care. Cost of PCI was added with total cost in 
medical ward as obtained before.
Cost calculation using activity based 
costing method was completed in two phases. 
In phase one, we calculated the capital and 
recurrent cost using step down method to 
determine cost of building, cost of utilities, 
cost of maintenance and cost of administration 
per day in medical ward. After that, this 
calculated cost is multiplied by patient length 
of stay (LOS) in medical ward to determine 
cost per episode of disease.
In the second phase, we calculated cost 
per activity using clinical pathways template to 
determine cost of treatment per episode of 
disease per patient. Cost calculated during the 
second phase is the staff salary, cost of 
consumables, cost of drugs, cost of procedure, 
and cost of investigation. The total cost is 
calculated by adding up both cost from phase 
one and phase two.
The mean cost from step down costing is 
then compared with activity based costing. The 
cost difference between both methods was 
taken as a result of study.
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RESULTS 
By using the step down methodology, the cost 
per day in managing STEMI using Clinical 
Cost Modeling (CCM) software is RM 
596.42(170.4USD). Each of the patients of 
STEMI remains in ward for more than one 
day; therefore the cost per day of treatment at 
the medical ward is then multiplied with the 
actual length of stay (LOS) in order to 
determine the actual cost of treatment for that 
episode of care for STEMI. The minimum cost 
per episode of care for STEMI was RM 
1,789.26(511.2USD) and maximum cost per 
episode of care was RM 
4,771.36(1363.2USD). Mean cost was RM 
3,340 (954.3USD (SD ±596.42 (170.4USD)) 
with average length of stay 5.6 days at 
UKMMC without cost of PCI. In order to get
the actual cost, the procedure cost should be 
added to medical ward cost. Patient has to pay 
for the procedure and the cost is RM 
13,950.00(3985.7USD).Therefore, the total 
cost of treatment of STEMI using the step 
down (case-mix) methodology was calculated 
to be RM 17,290.00(4940USD) (SD±596.42) 
(954.3USD). (Average cost of episode RM 
3,340(SD ±596.42) plus cost of PCI procedure 
RM 13,950.00).
There is no precedence for calculating the 
cost of coronary related procedure (PCI) in 
Malaysia. When we calculated the cost of 
treatment using the activity based costing 
(using clinical pathway), the average cost of 
treatment was RM 20,431.39(5837.5USD). 
The highest percentage was cost of procedure.
The detail of the cost component is shown in 
the Table 1.The study showed the difference is 
15.4%.
Table 1 Cost composition of STEMI (Primary PCI ) using activity based costing method
Item Cost Average Cost
Cost of Medical Ward(episode) 1033.85
Emergency Department 159.42







 Physiotherapy Activities 36.68
 Diet 102.08
 Elimination(waste) 2.00
Procedure                                         (PCI) 18,416.50
Total 20,431.39
DISCUSSION
According to James Vertres and Leon Paff step 
down costing method to estimates inpatient 
cost included eight steps. First study 
organization’s chart or account, second define 
cost centers, third grouped cost centers in to 
first-tier or overhead cost centers, second-tier 
or intermediate cost centers, third-tier or final 
care cost centers, fourth identify total cost of 
each overhead, intermediate and final cost 
center, fifth decide on units to distribute cost 
or to allocate cost, sixth allocate the cost of 
overhead cost centers to intermediate and final 
care cost centers, seventh allocate the costs of 
intermediate to final cost centers and eighth
related cost to case-mix group to determine 
cost per day16.
Now, the process to calculate cost per day 
in any ward in hospital become much easier by 
using Clinical Cost Modelling Software. 
Clinical Cost Modelling Software created 
based on three different conventional costing 
approach in hospital setting, namely step down 
(step down), activity based costing and case 
mix costing. It is much easier to use because 
user only needs to collect several  data on 
hospital’s performance, financial data and 
basic data that can be obtained from the 
hospital’s annual report17.
Cost in medical department for every 
admission of patients suffered with STEMI 
was RM 3,340 (SD 596.42) with average 
length of stay of 5.6 days (SD=1day). This 
result was almost similar with finding of  
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Amrizal et al 2005, mean cost of STEMI 
without comorbidity and complication (IR-
DRG 05331) was RM 3,699(1056USD) with 
length of stay 5.5 days.
This study found that average cost of 
STEMI with PCI procedure is RM RM 
13,950.00(3985.7USD). Percentage of ABC 
cost components are procedure (69%), drugs 
(21%), overhead cost (5%), investigation cost 
(3%), and salary (2%). According to Burnelli 
et al 1996 percentage of cost component in 
STEMI were interventional cardiology (25.7 
%), share facility (24.5%), drugs (19.8%), 
salary (13.9%) and laboratory (5.6 %) 18.
This study found that the cost of STEMI 
developed using the ABC was higher (15.4%) 
as compared to step down costing method. 
Cost of treatment  calculated by using activity 
based costing are higher because all resources 
used are incorporated in detail. These 
resources include; over head cost, salary, 
consumables, equipment, drugs, investigation, 
procedure and many more. Compared to step 
down costing, activity based costing was more 
time consuming and more people are involved. 
In this study, the data was collected from 
cardiologist, nurses, pysiotherapist, 
pharmacist, dietitian, cathlab managers, 
hematology and pathology managers, 
radiology managers, general store chief unit, 
equipment suppliers, finance staff, engineering 
staff  and human resources staff. However, 
activity based costing can describe the real cost 
in each activity of treatment. It also provides
data on cost component that contribute to the 
increased cost of treatment.
CONCLUSION
Step down Costing was calculated by using 
Clinical Cost Modeling (CCM) Software 
version 2.1. Financial data collected and 
running through the software are basic hospital 
utilization data, hospital performance, and 
some financial data. From the study the cost of 
Uncomplicated Acute ST Elevation 
Myocardial Infarction per episode of care was 
RM 3340(954USD) (SD=596.42). Total cost 
after added to the procedure cost was RM 
17,290.00(4940USD) (SD ±596.42 
(170.4USD)). Cost of treatment by activity 
based costing used clinical pathways of 
Uncomplicated Acute ST Elevation 
Myocardial Infarction as guide line. By this 
method it is found that cost of treatment per 
episode of care was RM 
20,431.39(5837.5USD). The study concluded 
the activity based costing method was higher 
than step down costing method with
approximately 15.4%.
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